Corton Capital Inc. decreased its stake in shares of Doximity, Inc. (NASDAQ:DOCS – Free Report) by 17.6% during the 4th quarter, Holdings Channel reports. The institutional investor owned 6,615 shares of the company’s stock after selling 1,409 shares during the period. Corton Capital Inc.’s holdings in Doximity were worth $353,000 as of its most recent SEC filing.
Several other institutional investors have also bought and sold shares of the stock. Global Retirement Partners LLC boosted its holdings in Doximity by 468.1% during the 4th quarter. Global Retirement Partners LLC now owns 534 shares of the company’s stock worth $29,000 after acquiring an additional 440 shares during the last quarter. UMB Bank n.a. lifted its position in shares of Doximity by 69.1% during the fourth quarter. UMB Bank n.a. now owns 575 shares of the company’s stock valued at $31,000 after purchasing an additional 235 shares in the last quarter. Larson Financial Group LLC lifted its position in shares of Doximity by 49.4% during the fourth quarter. Larson Financial Group LLC now owns 756 shares of the company’s stock valued at $40,000 after purchasing an additional 250 shares in the last quarter. Optimum Investment Advisors purchased a new position in Doximity during the fourth quarter worth about $43,000. Finally, Kapitalo Investimentos Ltda bought a new stake in Doximity in the 4th quarter worth about $50,000. Institutional investors own 87.19% of the company’s stock.
Wall Street Analyst Weigh In
Several equities analysts have commented on the stock. Truist Financial dropped their target price on shares of Doximity from $65.00 to $58.00 and set a “hold” rating on the stock in a research report on Thursday, April 10th. Morgan Stanley cut their price objective on Doximity from $71.00 to $60.00 and set an “equal weight” rating on the stock in a research report on Thursday, April 24th. The Goldman Sachs Group raised their target price on Doximity from $58.00 to $80.00 and gave the company a “neutral” rating in a research report on Monday, February 10th. Needham & Company LLC boosted their price target on shares of Doximity from $65.00 to $82.00 and gave the stock a “buy” rating in a report on Friday, February 7th. Finally, Raymond James restated an “outperform” rating and set a $83.00 price objective (up previously from $65.00) on shares of Doximity in a report on Friday, February 7th. Eleven equities research analysts have rated the stock with a hold rating, eight have issued a buy rating and two have assigned a strong buy rating to the stock. According to MarketBeat, Doximity currently has an average rating of “Moderate Buy” and an average target price of $65.39.
Insider Activity
In other Doximity news, Director Kira Scherer Wampler sold 2,000 shares of the business’s stock in a transaction on Thursday, May 1st. The shares were sold at an average price of $56.93, for a total value of $113,860.00. Following the completion of the sale, the director now directly owns 16,618 shares of the company’s stock, valued at $946,062.74. The trade was a 10.74 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available at the SEC website. Also, CFO Anna Bryson sold 45,000 shares of the stock in a transaction dated Thursday, May 1st. The shares were sold at an average price of $57.23, for a total value of $2,575,350.00. Following the sale, the chief financial officer now owns 357,165 shares of the company’s stock, valued at $20,440,552.95. This represents a 11.19 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Corporate insiders own 37.40% of the company’s stock.
Doximity Stock Down 3.8 %
Doximity stock opened at $57.13 on Wednesday. The stock has a market cap of $10.67 billion, a price-to-earnings ratio of 57.13, a PEG ratio of 4.10 and a beta of 1.41. The business has a 50-day simple moving average of $58.58 and a 200 day simple moving average of $56.90. Doximity, Inc. has a 52 week low of $22.96 and a 52 week high of $85.21.
Doximity Profile
Doximity, Inc operates a cloud-based digital platform for medical professionals in the United States. The company's platform provides its members with tools built for medical professionals, enabling them to collaborate with their colleagues, coordinate patient care, conduct virtual patient visits, stay up to date with the latest medical news and research, and manage their careers.
Featured Stories
- Five stocks we like better than Doximity
- Health Care Stocks Explained: Why You Might Want to Invest
- 3 Mid-Cap Medical Stocks Outperforming the Market
- The Basics of Support and Resistance
- The Top-Ranked Insider Buys From April by Market Cap
- Stock Trading Terms – Stock Terms Every Investor Needs to Know
- Is Eli Lilly a Buy After Weak Earnings and CVS-Novo Partnership?
Want to see what other hedge funds are holding DOCS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Doximity, Inc. (NASDAQ:DOCS – Free Report).
Receive News & Ratings for Doximity Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Doximity and related companies with MarketBeat.com's FREE daily email newsletter.